Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Future Microbiology|September 1, 2021
SARS-CoV-2: lessons from both the history of medicine and from the biological behavior of other well-known virusesSirio Fiorino, Fabio Tateo, Dario De Biase, et al.
Journal of Hepatology|October 27, 2011
Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor poolElisabetta Loggi, Lorenzo Micco, Giorgio Ercolani, et al.
Journal of Virology|September 19, 2008
Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoireAnthony Tanoto Tan, Elisabetta Loggi, Carolina Boni, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 23, 2016
Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled studySirio Fiorino, Elisabetta Loggi, Gabriella Verucchi, et al.
Prostaglandins & Other Lipid Mediators|January 15, 2022
The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infectionClaudio G Gallo, Sirio Fiorino, Giovanni Posabella, et al.
The New Microbiologica|June 21, 2021
Hepatitis C Virus Core Antigen (HCVAg): an affordable assay to monitor the efficacy of treatment in DAAs eraBarbara Rossetti, Elisabetta Loggi, Chiara Spertilli Raffaelli, et al.
Gut|July 20, 2024
HBcrAg values may predict virological and immunological responses to pegIFN-α in NUC-suppressed HBeAg-negative chronic hepatitis BAndrea Vecchi, Marzia Rossi, Camilla Tiezzi, et al.
Cell Genomics|June 30, 2023
Proteomics of immune cells from liver tumors reveals immunotherapy targetsFernando P Canale, Julia Neumann, Janusz von Renesse, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 21, 2017
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapiesVelia C Di Maio, Valeria Cento, Ilaria Lenci, et al.
Pageof 4